Kiper Christopher S
Transaction: 06/04/2026
BUY
Change
+25,907
Price
Not reported
Filing
06/08/2026
Type
BUY
Lifecore Biomedical, Inc.
LFCR • Drug Manufacturers - Specialty & Generic
$4.40
▲ +0.05 (+1.15%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$164.90M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.49Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.40
Change1.15%
Shares Out37.48M
Market Cap$164.90M
Enterprise Value$287.58M
52W Range3.63 - 8.98
Beta1.06
P/E-5.36
P/S1.27
P/B7.94
P/FCF26.47
EV/Sales2.22
Price$4.40
Change1.15%
Shares Out37.48M
Market Cap$164.90M
Enterprise Value$287.58M
52W Range3.63 - 8.98
Beta1.06
P/E-5.36
P/S1.27
P/B7.94
P/FCF26.47
EV/Sales2.22
EV/EBITDA23.97
EV/FCF46.16
Earnings Yield-18.67%
FCF Yield3.78%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-10.04
Current Ratio3.49
Quick Ratio2.26
Revenue 5Y-100.00%
Target$6.50
Target Upside47.73%
Target Median$6.50
Target Range6.50 - 6.50
Volume2.84K
Avg Volume200.58K
EPS Surprise-0.19
Investment DNA
How strong this company looks for long-term investors
31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Healthy liquidity · 3.49Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
86/100
Bullish
Bullish
5
Hold
2
Bearish
0
Price Target
2026-08-07
Low
$6.50
Mean
$6.50
Median
$6.50
High
$6.50
Insider Transactions
Recent executive and insider activity
HOUDE LOVAS KATRINA
Transaction: 06/04/2026
BUY
Change
+25,907
Price
Not reported
Filing
06/05/2026
Type
BUY
Johnson Paul Harold
Transaction: 06/04/2026
BUY
Change
+25,907
Price
Not reported
Filing
06/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kiper Christopher S | BUY | +25,907 | Not reported | 06/04/2026 | 06/08/2026 |
| HOUDE LOVAS KATRINA | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Johnson Paul Harold | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Antunes Humberto Calheiros | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Korenberg Matthew E | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Schechter Joshua | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Aryeh Jason | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| OBUS NELSON | BUY | +25,907 | Not reported | 06/04/2026 | 06/05/2026 |
| Josephs Paul | SELL | -40,413 | $4.57 | 05/20/2026 | 05/21/2026 |
| Salus Thomas D. | SELL | -24,645 | $5.20 | 04/14/2026 | 04/16/2026 |
| Salus Thomas D. | BUY | +30,000 | Not reported | 03/02/2026 | 03/02/2026 |
| Lake Ryan David | SELL | -22,932 | $7.71 | 09/03/2025 | 09/04/2025 |
| HOUDE LOVAS KATRINA | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Schechter Joshua | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Antunes Humberto Calheiros | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Korenberg Matthew E | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Aryeh Jason | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Johnson Paul Harold | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| Kiper Christopher S | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |
| OBUS NELSON | BUY | +19,506 | Not reported | 07/15/2025 | 07/17/2025 |